White Paper

New Developments In IDMP: What You Need To Know, And What You Can Do Today

Source: Phlexglobal
Phlex IDMP

The Identification of Medicinal Products1 (IDMP) initiative from the ISO continues to progress and take shape, with timelines starting to firm up. While there is still much work to be done, agencies such as the EMA have already taken several concrete steps to help organizations prepare for IDMP.

In this Executive Brief, Phlexglobal’s regulatory and technology experts examine the latest major development from the EMA: The February 2020 release of version 1 of the IDMP Product Management Services Implementation Guide2 (“EU IG v1”) for the submission of data on medicinal products.

Based on careful analysis of the implementation guide and our experience successfully managing hundreds of compliance projects worldwide, we provide practical recommendations and real-world use cases to help Marketing Authorization Holders in the EU and EEA streamline their preparations for IDMP.

The recommendations and guidance in this brief are also informed by Phlexglobal’s active involvement in the relevant agency working groups, as well as our comprehensive support helping some of the world’s largest pharmaceutical companies prepare for IDMP.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader